The clinicopathologic significance of preoperative serum-soluble interleukin-2 receptor concentrations in operable non-small cell lung cancer patients

Background Serum-soluble interleukin-2 receptor (IL-2R) concentrations have been found to be elevated in cancer patients. However, the importance of this finding in patients with non-small-cell lung cancer (NSCLC) has not been previously established.